Lawsuit Information Center

April 27, 2026

3M Earplug Lawsuit Update

This page provides the latest news and updates on the 3M earplug lawsuits and the settlement in 2024. We continue to update this page to provide information to victims, but you can find even more quality information from other plaintiffs in the over 10,000 comments below. We are not handling new 3M earplug lawsuits. Continue reading

April 27, 2026

Florida Sex Abuse Lawsuits

by Ronald V. Miller, Jr.

Victims of sexual abuse or sexual assault have the right to file civil lawsuits and get financial compensation. Recent changes in the law are now making it easier for abuse victims to seek justice in the civil courts. This post will discuss how sex abuse victims can file civil lawsuits in Florida and look at the potential settlement value of these cases.

Florida Sex Abuse Lawsuit News and Updates

May 1, 2026: New Miami School Sexual Abuse Lawsuit

April 26, 2026

Internal Bra Mesh Lawsuit

by Ronald V. Miller, Jr.

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

April 24, 2026

Ozempic Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.

Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.

April 24, 2026

Roblox Child Sex Abuse Lawsuit

by Ronald V. Miller, Jr.

A growing number of families are suing Roblox after learning their children were groomed, exploited, or exposed to sexually explicit content through the platform. Roblox spent years branding itself as a safe, kid-focused place to create and play. These lawsuits say that the promise did not match reality, and too many children have been exploited as a result.

Several high-profile cases, including a federal lawsuit filed in Texas and consumer class action claims over marketing and monetization practices, allege that Roblox failed to protect minors from foreseeable risks. In federal court, most of the child exploitation and grooming cases are now coordinated in the Roblox MDL in the Northern District of California, Case No. 25-md-03166-RS, before Chief Judge Richard Seeborg, as we explain below

The core allegations are straightforward. Families claim Roblox allowed predators and explicit content to circulate, failed to enforce meaningful safety barriers, and profited from design choices that kept kids engaged while leaving them vulnerable. Many complaints describe the same pattern: predators initiate contact through in-game chat or messaging, build trust, and then push children to move conversations to third-party apps like Discord or Snapchat, where monitoring is weaker, and the harm escalates.

April 21, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.

April 21, 2026

Zantac Lawsuit Update

by Ronald V. Miller, Jr.

Our attorneys also provide the latest updates on the Zantac class action lawsuit (including the disastrous news that the class action judge dismissed all federal court Zantac lawsuits). This page was updated on April 21, 2026.

Zantac Cancer Lawsuit Updates 2026

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has taken many turns.

April 20, 2026

Hair Relaxer Lawsuit

by Ronald V. Miller, Jr.

Our lawyers are actively reviewing hair relaxer cancer lawsuits across all 50 states. This page provides:

Detailed news and updates on the chemical hair relaxer litigation,
Insights from our hair relaxer attorneys on how these lawsuits may unfold,

April 19, 2026

Utah Personal Injury Verdicts and Settlements

by Ronald V. Miller, Jr.

This page explores settlement amounts and jury payouts in personal injury and medical malpractice lawsuits in Utah. Our attorneys also provide an analysis of Utah personal injury law.

If you are a victim of personal injury initiating a compensation claim in Utah, you’ll want to know the potential range of settlement payouts for your case. Why? Because the ultimate aim of a personal injury or wrongful death claim is financial compensation. That is all the civil justice system can give you: money.

This page is designed to examine how personal injury and medical malpractice lawsuits in Utah have been resolved. You will be tempted to align your claim with Utah personal injury settlement statistics, example settlements, and jury payouts.

April 19, 2026

Olympus Scope Lawsuit

by Ronald V. Miller, Jr.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died. The infections were caused by drug-resistant bacteria that no antibiotic could reliably kill. The patients had gone into the hospital for routine diagnostic procedures–gallstone evaluations, pancreatic biopsies, bile duct imaging–and came out with infections that would destroy their organs, land them in intensive care for months, or kill them outright.

The remarkable part is not that it happened. Medical devices fail. Infections occur. What makes the Olympus duodenoscope litigation extraordinary is that the company knew. Olympus knew its scopes could not be adequately cleaned. Olympus knew that bacteria were surviving the sterilization process and spreading from patient to patient. Olympus knew that people were dying. And for years, the company did almost nothing.

This page explains what went wrong, why it went wrong, and the legal options available to patients and families harmed by contaminated Olympus scopes. It is long. It is detailed. It is written for people who want to understand not just the claims being filed, but the science, the regulatory failures, and the corporate decisions that turned a solvable engineering problem into a public health catastrophe.